Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapies.
作者信息
de Jong M D, Boucher C A, Cooper D A, Galasso G J, Gazzard B, Lange J M, Montaner J S, Richman D D, Thomas H C
机构信息
Department of Medical Microbiology, Academic Medical Center, Amsterdam, The Netherlands.
出版信息
Antiviral Res. 1997 Jul;35(2):65-82. doi: 10.1016/s0166-3542(97)00020-x.
Abstract
摘要
相似文献
1
Summary of the II International Consensus Symposium on Combined Antiviral Therapy and implications for future therapies.第二届抗病毒联合治疗国际共识研讨会总结及对未来治疗的启示。
Antiviral Res. 1997 Jul;35(2):65-82. doi: 10.1016/s0166-3542(97)00020-x.
2
Consensus symposium on combined antiviral therapy. International Society for Antiviral Research and the National Institutes of Allergy and Infectious Diseases.联合抗病毒治疗共识研讨会。国际抗病毒研究学会与美国国立过敏和传染病研究所。
Antiviral Res. 1996 Jan;29(1):5-29. doi: 10.1016/0166-3542(95)00910-8.
3
Summary of the III International Consensus Symposium on Combined Antiviral Therapy.第三届联合抗病毒治疗国际共识研讨会综述
Antiviral Res. 1998 May;38(2):75-93. doi: 10.1016/s0166-3542(98)00021-7.
4
Consensus symposium on combined antiviral therapy. Lisbon, Portugal, July 25-27.联合抗病毒治疗共识研讨会。葡萄牙里斯本，7月25日至27日。
Antiviral Res. 1996 Jan;29(1):3-122. doi: 10.1016/0166-3542(95)00909-4.
5
Current and future antiviral agents for chronic hepatitis B.慢性乙型肝炎的现有及未来抗病毒药物
J Antimicrob Chemother. 2003 Mar;51(3):481-5. doi: 10.1093/jac/dkg122.
6
The implications of drug resistance for strategies of combination antiviral chemotherapy.耐药性对抗病毒联合化疗策略的影响。
Antiviral Res. 1996 Jan;29(1):31-3. doi: 10.1016/0166-3542(95)00911-6.
7
Combination therapy for hepatitis B.乙型肝炎的联合治疗
Gut. 2002 Apr;50(4):443-5. doi: 10.1136/gut.50.4.443.
8
Combination Antiretroviral Therapy for HIV Infection. Proceedings of an international symposium. Berlin, Germany, March 25-26, 1995.用于HIV感染的抗逆转录病毒联合疗法。国际研讨会会议记录。德国柏林，1995年3月25 - 26日。
J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:v, S1-82.
9
Future prospects for antiviral agents and new approaches.抗病毒药物的未来前景及新方法
J Antimicrob Chemother. 1984 Aug;14 Suppl A:127-36. doi: 10.1093/jac/14.suppl_a.127.
10
The faster the better?越快越好？
Intern Emerg Med. 2006;1(2):91-3. doi: 10.1007/BF02936531.
本文引用的文献
1
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation.原位肝移植后复发性感染时给予拉米夫定的乙肝病毒耐药性。
Lancet. 1997 Jan 4;349(9044):20-2. doi: 10.1016/S0140-6736(96)02266-0.
2
Summary of the International Consensus Symposium on Advances in the Diagnosis, Treatment and Prophylaxis and Cytomegalovirus Infection.国际巨细胞病毒感染诊断、治疗、预防进展共识研讨会综述
Antiviral Res. 1996 Nov;32(3):119-40. doi: 10.1016/s0166-3542(96)01006-6.
3
Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.白细胞介素-2输注治疗人类免疫缺陷病毒感染患者的对照试验。
N Engl J Med. 1996 Oct 31;335(18):1350-6. doi: 10.1056/NEJM199610313351803.
4
Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.普通人群及卡波西肉瘤患者中针对人类疱疹病毒8型的抗体
Lancet. 1996 Sep 28;348(9031):858-61. doi: 10.1016/S0140-6736(96)03240-0.
5
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.每立方毫米有200至500个CD4细胞的HIV感染成年患者接受核苷治疗后病毒学和免疫学标志物与临床结局的关系。艾滋病临床试验组研究175病毒学研究团队。
N Engl J Med. 1996 Oct 10;335(15):1091-8. doi: 10.1056/NEJM199610103351502.
6
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.乙肝病毒RNA依赖的DNA聚合酶突变在体内赋予对拉米夫定的耐药性。
Hepatology. 1996 Sep;24(3):714-7. doi: 10.1002/hep.510240340.
7
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine.在接受拉米夫定治疗的移植受者中，乙型肝炎病毒聚合酶突变的选择
Hepatology. 1996 Sep;24(3):711-3. doi: 10.1002/hep.510240339.
8
Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation.骨髓移植期间口服疱疹病毒的阿昔洛韦预防
Eur J Cancer B Oral Oncol. 1996 May;32B(3):158-62. doi: 10.1016/0964-1955(95)00091-7.
9
Strategies for phase II cancer chemoprevention trials: cervix, endometrium, and ovary.II期癌症化学预防试验策略：子宫颈、子宫内膜和卵巢。
J Cell Biochem Suppl. 1995;23:1-9. doi: 10.1002/jcb.240590902.
10
CMV retinitis: ganciclovir/monoclonal antibody.巨细胞病毒性视网膜炎：更昔洛韦/单克隆抗体。
Antiviral Res. 1996 Jan;29(1):73-5. doi: 10.1016/0166-3542(95)00922-1.
Zotero 插件